Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
Abstract The wider use of clozapine is limited by the risk of agranulocytosis and the associated requirement for monitoring of neutrophil counts. We searched local electronic patient records for cases of agranulocytosis occurring during clozapine treatment during the period 2007–2020. We found 23 ep...
Main Authors: | David Taylor, Kalliopi Vallianatou, Eromona Whiskey, Olubanke Dzahini, James MacCabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-03-01
|
Series: | npj Schizophrenia |
Online Access: | https://doi.org/10.1038/s41537-022-00232-0 |
Similar Items
-
Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis
by: Alastair Green, et al.
Published: (2019-05-01) -
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
by: Ebenezer Oloyede, et al.
Published: (2023-06-01) -
Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
by: B. Jorge, et al.
Published: (2021-04-01) -
Agranulocytosis and cardiac toxicity - serious side effects of clozapine
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01) -
Vortioxetine as adjunctive therapy in the treatment of schizophrenia
by: Sofia Redaelli, et al.
Published: (2022-07-01)